Mobile

A single center open-label uncontrolled study to investigate tumour response and vascularization changes in neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable renal ce...

Mise à jour : Il y a 4 ans
Référence : ISRCTN46317673

A single center open-label uncontrolled study to investigate tumour response and vascularization changes in neoadjuvant therapy with BAY 43-9006 single agent therapy in patients with operable renal cell cancer

Femme et Homme

  • | Pays :
  • Netherlands
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Not provided at time of registration

Critère d'inclusion

  • Renal Cell Cancer

Liens